Soluble Receptors for Tumor Necrosis Factor as Predictors of Progression to AIDS in Asymptomatic Human Immunodeficiency Virus Type 1 Infection, Journal of Infectious Diseases, vol.169, issue.4, pp.739-745, 1994. ,
DOI : 10.1093/infdis/169.4.739
Soluble Tumor Necrosis Factor Receptors as Surrogate Markers for the Assessment of Zidovudine Treatment in Asymptomatic HIV-1 Infection, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, vol.10, issue.5, pp.531-539, 1995. ,
DOI : 10.1097/00042560-199510050-00006
The Prognostic Value of Cellular and Serologic Markers in Infection with Human Immunodeficiency Virus Type 1, New England Journal of Medicine, vol.322, issue.3, pp.166-172, 1990. ,
DOI : 10.1056/NEJM199001183220305
Serum HIV???1 RNA Levels Compared to Soluble Markers of Immune Activation to Predict Disease Progression in HIV???1???Infected Individuals, International Archives of Allergy and Immunology, vol.116, issue.3, pp.228-239, 1998. ,
DOI : 10.1159/000023949
Tumor Necrosis Factor (TNF) System Levels in Human Immunodeficiency Virus???Infected Patients during Highly Active Antiretroviral Therapy: Persistent TNF Activation Is Associated with Virologic and Immunologic Treatment Failure, The Journal of Infectious Diseases, vol.179, issue.1, pp.74-82, 1999. ,
DOI : 10.1086/314572
Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy, Clinical Immunology, vol.99, issue.3, pp.347-352, 2001. ,
DOI : 10.1006/clim.2001.5033
Predicting Clinical Progression or Death in Subjects with Early???Stage Human Immunodeficiency Virus (HIV) Infection: A Comparative Analysis of Quantification of HIV RNA, Soluble Tumor Necrosis Factor Type II Receptors, Neopterin, and $\beta _{2}$ -Microglobulin, The Journal of Infectious Diseases, vol.176, issue.5, pp.1161-1167, 1997. ,
DOI : 10.1086/514108
Correlations of soluble interleukin-2 and tumor necrosis factor type II receptors with immunologic and virologic responses under HAART ,
Platelet-activating factor, J Biol Chem, vol.268, pp.17381-17384, 1996. ,
Platelet-activating Factor Induces NF-??B Activation through a G Protein-coupled Pathway, Journal of Biological Chemistry, vol.270, issue.25, pp.14928-14934, 1995. ,
DOI : 10.1074/jbc.270.25.14928
Infection of human macrophages with an endogenous tumour necrosis factor-?? (TNF-??)-independent human immunodeficiency virus type 1 isolate is unresponsive to the TNF-?? synthesis inhibitor RP 55778, Journal of General Virology, vol.75, issue.6, pp.1379-1388, 1994. ,
DOI : 10.1099/0022-1317-75-6-1379
Molecular cloning and expression of platelet-activating factor receptor from human leukocytes, J Biol Chem, vol.266, pp.20400-20405, 1991. ,
Platelet-activating factor acetylhydrolases in health and disease, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1488, issue.1-2, pp.102-123, 2000. ,
DOI : 10.1016/S1388-1981(00)00114-1
Expression of antioxidant enzymes in human inflammatory cells, Am J Physiol Cell Physiol, vol.278, pp.118-125, 2000. ,
Glutathione deficiency is associated with impaired survival in HIV disease, Proceedings of the National Academy of Sciences, vol.94, issue.5, pp.1967-1972, 1997. ,
DOI : 10.1073/pnas.94.5.1967
Intracellular GSH content and HIV replication in human macrophages, J Leukoc Biol, vol.62, pp.54-59, 1997. ,
Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus., Proceedings of the National Academy of Sciences, vol.87, issue.24, pp.9943-9947, 1990. ,
DOI : 10.1073/pnas.87.24.9943
Plasma HIV RNA as predictor of long-term increase of CD4 cell counts in human immunodeficiency virus-infected patients initiating a protease-inhibitor containing regimen, J Infect Dis, vol.185, pp.471-480, 2002. ,
Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR Morb Mortal Wkly Rep, vol.41, pp.1-19, 1992. ,
Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic Response, Annals of Internal Medicine, vol.126, issue.12, pp.929-938, 1997. ,
DOI : 10.7326/0003-4819-126-12-199706150-00001
Plasma Viral Load and CD4+ Lymphocytes as Prognostic Markers of HIV-1 Infection, Annals of Internal Medicine, vol.126, issue.12, pp.946-954, 1997. ,
DOI : 10.7326/0003-4819-126-12-199706150-00003
The role of immunologic and viral markers in predicting clinical outcome in HIV infection, AIDS, vol.10, pp.21-25, 1996. ,
DOI : 10.1097/00002030-199612005-00004
Evaluation of measurement of human TNF in plasma by ELISA, Lymphok Cytok Res, vol.10, pp.69-76, 1991. ,
Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors, Journal of Experimental Medicine, vol.175, issue.2, pp.323-329, 1992. ,
DOI : 10.1084/jem.175.2.323
Increased Soluble Tumor Necrosis Factor Receptor Expression and Release by Human Immunodeficiency Virus Type 1 Infection, Journal of Interferon & Cytokine Research, vol.15, issue.9, pp.749-757, 1995. ,
DOI : 10.1089/jir.1995.15.749
CD38 Expression on CD8 T Lymphocytes as a Marker of Residual Virus Replication in Chronically HIV-Infected Patients Receiving Antiretroviral Therapy, AIDS Research and Human Retroviruses, vol.20, issue.2, pp.227-233, 2004. ,
DOI : 10.1089/088922204773004950
Assessment of CD8+ T cell immune activation markers to monitor response to antiretroviral therapy among HIV-1 infected patients in Cote d'Ivoire, Clinical and Experimental Immunology, vol.5, issue.1, pp.138-148, 2005. ,
DOI : 10.1159/000069339
CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy, HIV Medicine, vol.18, issue.2, pp.118-125, 2008. ,
DOI : 10.1038/nm1511
4-1BBL Induces TNF Receptor-Associated Factor 1-Dependent Bim Modulation in Human T Cells and Is a Critical Component in the Costimulation-Dependent Rescue of Functionally Impaired HIV-Specific CD8 T Cells, The Journal of Immunology, vol.179, issue.12, pp.8252-8263, 2007. ,
DOI : 10.4049/jimmunol.179.12.8252
Is HIV infection a TNF receptor signalling-driven disease?, Trends in Immunology, vol.29, issue.2, pp.61-67, 2008. ,
DOI : 10.1016/j.it.2007.10.008
URL : https://hal.archives-ouvertes.fr/hal-00464761
Interaction of SIV/SHIV infection and morphine on plasma oxidant/antioxidant balance in macaque, Molecular and Cellular Biochemistry, vol.63, issue.1-2, pp.169-175, 2008. ,
DOI : 10.1007/s11010-007-9625-0
-Lipoic Acid Supplementation in Patients with HIV Infection, The Journal of Alternative and Complementary Medicine, vol.14, issue.2, pp.139-146, 2008. ,
DOI : 10.1089/acm.2006.6397
Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults, Am J Clin Nutr, vol.85, pp.173-181, 2007. ,
Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor, J Virol, vol.63, pp.4404-4408, 1989. ,
Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1, J Virol, vol.66, pp.2217-2225, 1992. ,
HIV- 1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state, EMBO J, vol.14, pp.546-554, 1995. ,
Cytokines and HIV-1: Interactions and Clinical Implications, Antiviral Chemistry and Chemotherapy, vol.11, issue.3, pp.133-150, 2001. ,
DOI : 10.1038/382829a0
The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro, Clinical and Experimental Immunology, vol.4, issue.1, pp.123-129, 2000. ,
DOI : 10.1073/pnas.95.15.8869
Thalidomide for the Treatment of Oral Aphthous Ulcers in Patients with Human Immunodeficiency Virus Infection, New England Journal of Medicine, vol.336, issue.21, pp.1487-1493, 1997. ,
DOI : 10.1056/NEJM199705223362103
Prevention of opportunistic infections in HIV infection by pentoxyphylline, Indian J Med Res, vol.124, pp.705-708, 2006. ,
Elevated levels of interleukin- 6 and D-dimer are associated with an increased risk of death in patents with HIV, 15th Conference on Retroviruses and Opportunistic Infections, 2008. ,
Relationship of Plasma HIV-RNA Levels and Levels of TNF-?? and Immune Activation Products in HIV Infection, Clinical Immunology and Immunopathology, vol.84, issue.1, pp.36-45, 1997. ,
DOI : 10.1006/clin.1997.4364